Therapeutic management of ocular adnexal MALT lymphoma (Q36964741)

17 August 2017

1 reference

title

Therapeutic management of ocular adnexal MALT lymphoma (English)

1 reference

17 August 2017

Letterio S Politi

6

0 references

Riccardo Dolcetti

object named as

Riccardo Dolcetti

9

0 references

Claudio Doglioni

object named as

Claudio Doglioni

7

0 references

author name string

Andres J M Ferreri

1

1 reference

17 August 2017

Andrea Assanelli

2

1 reference

17 August 2017

Roberto Crocchiolo

3

1 reference

17 August 2017

Giuseppina P Dognini

4

1 reference

17 August 2017

Antonio Giordano Resti

5

1 reference

17 August 2017

Federico Caligaris Cappio

8

1 reference

17 August 2017

Maurilio Ponzoni

10

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 June 2007

1 reference

Expert Opinion on Pharmacotherapy

17 August 2017

published in

1 reference

17 August 2017

volume

8

1 reference

17 August 2017

issue

8

1 reference

17 August 2017

page(s)

1073-1083

1 reference

Mucosa-associated lymphoid tissue lymphoma with intraocular involvement

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517/14656566.8.8.1073

Ocular adnexal lymphoma: a review of clinicopathologic features and treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.8.1073

Ocular adnexal lymphoma: clinical behavior of distinct World Health Organization classification subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.8.1073

Molecular pathogenesis of mucosa-associated lymphoid tissue lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.8.1073

Ocular adnexal lymphoma: a clinicopathologic study of a large cohort of patients with no evidence for an association with Chlamydia psittaci

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.8.1073

Is there an association between ocular adnexal lymphoma and infection with Chlamydia psittaci? The University of Rochester experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.8.1073

Absence of Chlamydia psittaci in ocular adnexal lymphoma from Japanese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.8.1073

Chlamydia psittaci is variably associated with ocular adnexal MALT lymphoma in different geographical regions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.8.1073

Long-term follow-up results of no initial therapy for ocular adnexal MALT lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.8.1073

Ophthalmologic and intraocular non-Hodgkin's lymphoma: a large single centre study of initial characteristics, natural history, and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.8.1073

Oral chlorambucil for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue of the orbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.8.1073

Regression of ocular adnexal lymphoma after Chlamydia psittaci-eradicating antibiotic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.8.1073

Curative radiotherapy for primary orbital lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.8.1073

Radiation therapy for primary orbital lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.8.1073

Results of radiotherapy in patients with stage I orbital non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.8.1073

Outcome and prognostic factors in orbital lymphoma: a Rare Cancer Network study on 90 consecutive patients treated with radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.8.1073

Ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.8.1073

Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: a multiinstitutional, retrospective review of 50 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.8.1073

Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.8.1073

Treatment results of radiotherapy for malignant lymphoma of the orbit and histopathologic review according to the WHO classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.8.1073

Primary radiotherapy for localized orbital MALT lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.8.1073

Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.8.1073

Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue of the head and neck area: high rate of disease recurrence following local therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.8.1073

Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.8.1073

Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with cladribine: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.8.1073

Phase II study of oxaliplatin for treatment of patients with mucosa-associated lymphoid tissue lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.8.1073

Association between Helicobacter pylori infection and MALT-type lymphoma of the ocular adnexa: clinical and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.8.1073

Antibiotic treatment is not effective in patients infected with Helicobacter pylori suffering from extragastric MALT lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.8.1073

'Blind' antibiotic treatment targeting Chlamydia is not effective in patients with MALT lymphoma of the ocular adnexa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.8.1073

Periocular mucosa-associated lymphoid/low grade lymphomas: treatment with antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.8.1073

Clinical implications of hepatitis C virus infection in MALT-type lymphoma of the ocular adnexa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.8.1073

Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.8.1073

Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.8.1073

Clinical activity of rituximab in gastric marginal zone non-Hodgkin's lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.8.1073

Interferon treatment of childhood conjunctival lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.8.1073

Monoclonal antibody treatment of orbital lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.8.1073

Nongastrointestinal mucosa-associated lymphoid tissue (MALT) lymphomas: Clinical and therapeutic features of 24 localized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.8.1073

Rituximab in primary conjunctiva lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.8.8.1073

10.1517/14656566.8.8.1073

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference